Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001641172-25-013237
Filing Date
2025-06-02
Accepted
2025-06-02 16:05:32
Documents
3
Period of Report
2025-06-02

Document Format Files

Seq Description Document Type Size
1 DEF 14A formdef14a.htm DEF 14A 729370
2 GRAPHIC proxy_001.jpg GRAPHIC 279920
3 GRAPHIC proxy_002.jpg GRAPHIC 155937
  Complete submission text file 0001641172-25-013237.txt   1293716
Mailing Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130 (858)-223-0882
Dermata Therapeutics, Inc. (Filer) CIK: 0001853816 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40739 | Film No.: 251014938
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)